Prevalence of variants in candidate genes for type 2 diabetes mellitus in the Netherlands: The Rotterdam study and the Hoorn study

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1002-1006

  'T Hart, Leen M ^a   Stolk, Ronald P ^b,c   Dekker, Jacqueline M ^d   Nijpels, Giel ^d   Grobbee, Diederick E ^b,c   Heine, Robert J ^d   Maassen, J Antonie ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; ARGININE; BLOOD CLOTTING FACTOR 5; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; METHIONINE;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032988612     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.1002     Document Type: Article

References (32)

1. De Fronzo RA. 1997 Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177-285.
2. Kahn CR, Vicent D, Doria A. 1996 Genetics of non-insulin-dependent (type II) diabetes mellitus. Annu Rev Med. 47:509-531.
3. Velho G, Froguel P. 1997 Genetic determinants of non-insulin-dependent diabetes mellitus: strategies and recent results. Diabetes Metab. 23:7-17.
4. 40Ser) with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Practice. 32:183-185.
5. Altshuler D, Kruglyak L, Lander E. 1998 Genetic polymorphisms and disease. N Engl J Med. 338:1626.
6. Burning JC, Winnay J, Bonnerweir S, Taylor SI, Accili D, Kahn CR. 1997 Development of a novel poiygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
7. Terauchi Y, Iwamoto K, Tamemoto H, et al. 1997 Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes-genetic reconstitution of diabetes as a polygenic disease. J Clin Invest. 99:861-866.
8. 't Hart LM, Stolk RP, Heine RJ, Grobbee DE, van der Does FEE, Maassen JA. 1996 Association of the insulin-receptor variant met-985 with hyperglycaemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study. Am J Hum Genet. 59:1119-1125.
9. Mooy J, Grootenhuis P, de Vries H, et al. 1995 Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn study. Diabetes Care. 18:1270-1273.
10. Sakagashira S, Sanke T, Hanabusa T, et al. 1996 Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes. 45:1279-1281.
11. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. 1993 Aminoacid polymorphisms of insulin receptor substrate-1 in non insulin dependent diabetes mellitus. Lancet. 342:828-832.
12. Krekora K, Delucía D, Capani F, Donati MD, Iacoviello L. 1996 Association of coagulation factor V-arg506gln mutation with non-insulin-dependent diabetes mellitus. Lancet 348:1666-1667.
13. Stolk RP, Pols HAP, Lamberts SWJ, de Jong PTVM, Hofman A, Grobbee DE. 1997 Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population-the Rotterdam study. Am J Epidemiol. 145:24-32.
14. Hansen L, Hansen T, Clausen JO, et al. 1997 The val985 met insulin-receptor variant in the Danish Caucasian population: lack of associations with non-insulin-dependent diabetes mellitus or insulin resistance. Am J Hum Genet. 60:1532-1535.
15. O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, Moller DE. 1991 Detection of mutations in the insulin receptor gene in NIDDM patients by analysis of single stranded conformation polymorphisms. Diabetes. 40:777-782.
16. O'Rahilly S, Krook A, Morgan R, Rees A, Flier JS, Moller DE. 1992 Insulin receptor and insulin responsive glucose transporter (GLUT4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia. 35:486-489.
17. Lepretre F, Vionnet N, Budhan S, et al. 1998 Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab. 24:244-250.
18. Inoue H, Ferrer J, Welling CM, et al. 1996 Sequence variants in the sulfonylurea receptor (SUR) gene arc associated with NIDDM in Caucasians. Diabetes. 45:825-831.
19. Strack V, Bossenmaier B, Stoyanov B, Mushack J, Haring HU. 1997 A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and shc in HEK 293 cells. Diabetologia. 40:1135-1140.
20. Birch C, Fagan I, Amstrong M, Turnbull D, Walker M. 1997 The S20G islet-associated polypeptide gene mutation in familial NIDDM. Diabetologia. 40:1113.
21. Chuang LM, Lee KC, Huang CN, Wu HP, Tai TY, Lin BJ. 1998 Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients. Diabetologia. 41:1250-1251.
22. Bertina R, Koeleman B, Koster T, et al. 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:64-67.
23. Ridker P, Miletich T, Hennekens C, Buring J. 1997 Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 277:1305-1307.
24. Odawara M, Yamashita K. 1997 Factor V Leiden mutation and Japanese NIDDM. Diabetologia. 40:1363-1364.
25. Maser RE, Miele ME, Lenhard MJ, et al. 1998 Lack of association of factor V Leiden and coronary heart disease in individuals with and without diabetes. Diabetes Care. 21:198.
26. Sigal RJ, Doria A, Warram JH, Krolewski AS. 1996 Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 81:1657-1659.
27. 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. Diabetologia. 39:1505-1511.
28. Clausen JO, Hansen T, Bjorbaek C, et al. 1995 Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet. 346:397-402.
29. 972Arg variant of the insulin receptor substrate-1 to increase insulin resistance. Proc of Genetics of Diabetes, Sweden. 1997; 35.
30. Almind K, Inoue G, Pedersen O, Kahn CR. 1996 A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signalling-evidence from transfection studies. J Clin Invest. 97:2569-2575.
31. Hansen T, Echwald SM, Hansen L, et al. 1997 Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high affinity sulfonylurea receptor gene. Diabetes. 47:598-605.
32. 't Hart LM, Ruige JB, Dekker JM, Nijpels G, Maassen JA, Heine RJ. 1998 Reduced β-cell function and blood pressure in carriers of intron 16 -3t variant of the sulfonylurea receptor gene [Abstract]. Diabetologia. 41(Suppl 1):A33-A122.